creating transparency to have drug rebates unlocked ( c-thru ) act of 2017 this bill amends title xi ( general provisions ) of the social security act ( ssact ) to require the public disclosure of certain information provided to the department of health and human services ( hhs ) by a pharmacy benefit manager ( pbm ) that contracts with : ( 1 ) a prescription drug plan ( pdp ) under medicare or medicare advantage ( ma ) , or ( 2 ) a qualified health benefits plan offered through an exchange established under the patient protection and affordable care act .
specifically , hhs must publish on its website , with respect to each pbm , information regarding : ( 1 ) the amount and type of rebates and discounts negotiated by the pbm and the extent to which these rebates and discounts are passed on to the plan sponsor , and ( 2 ) the difference between the amount paid by the plan sponsor to the pbm and the amount paid by the pbm to pharmacies .
as a condition of participation as a contractor under medicare or ma , a pbm must pass on to a pdp sponsor a minimum percentage , as established by hhs , of the amount of rebates and discounts negotiated by the pbm that are attributable to patient utilization under the plan .
the bill also amends title xviii ( medicare ) of the ssact to modify requirements regarding enrollees ' access to negotiated drug prices .
current law requires a pdp sponsor to provide enrollees in medicare or ma with access to negotiated drug prices that account for rebates and discounts .
the bill requires that , with respect to a covered drug , a negotiated price ( or , if necessary , an approximate negotiated price ) be provided at the point of sale .